Your browser doesn't support javascript.
loading
Identification of a High-Level MET Amplification in CTCs and cfTNA of an ALK-Positive NSCLC Patient Developing Evasive Resistance to Crizotinib.
Berger, Lars-Arne; Janning, Melanie; Velthaus, Janna-Lisa; Ben-Batalla, Isabel; Schatz, Stefanie; Falk, Markus; Iglauer, Peter; Simon, Ronald; Cao, Ru; Forcato, Claudio; Manaresi, Nicolò; Bramlett, Kelli; Buson, Genny; Hanssen, Annkathrin; Tiemann, Markus; Sauter, Guido; Bokemeyer, Carsten; Riethdorf, Sabine; Reck, Martin; Pantel, Klaus; Wikman, Harriet; Loges, Sonja.
Afiliación
  • Berger LA; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Janning M; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Tumor Biology, Center of Experimental Medicine, University Medical Ce
  • Velthaus JL; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Tumor Biology, Center of Experimental Medicine, University Medical Ce
  • Ben-Batalla I; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Tumor Biology, Center of Experimental Medicine, University Medical Ce
  • Schatz S; Institute of Hematopathology Hamburg (HpH), Hamburg, Germany.
  • Falk M; Institute of Hematopathology Hamburg (HpH), Hamburg, Germany.
  • Iglauer P; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Simon R; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Cao R; Thermo Fisher Scientific, Austin, Texas.
  • Forcato C; Menarini Silicon Biosystems, Bologna, Italy.
  • Manaresi N; Menarini Silicon Biosystems, Bologna, Italy.
  • Bramlett K; Thermo Fisher Scientific, Austin, Texas.
  • Buson G; Menarini Silicon Biosystems, Bologna, Italy.
  • Hanssen A; Department of Tumor Biology, Center of Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Tiemann M; Institute of Hematopathology Hamburg (HpH), Hamburg, Germany.
  • Sauter G; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Bokemeyer C; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Riethdorf S; Department of Tumor Biology, Center of Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Reck M; Lung Clinic Grosshansdorf, Airway Research Center North, German Center of Lung Research, Grosshansdorf, Germany.
  • Pantel K; Department of Tumor Biology, Center of Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Wikman H; Department of Tumor Biology, Center of Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Loges S; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Tumor Biology, Center of Experimental Medicine, University Medical Ce
J Thorac Oncol ; 13(12): e243-e246, 2018 12.
Article en En | MEDLINE | ID: mdl-30205165

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Amplificación de Genes / Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Proteínas Proto-Oncogénicas c-met / Crizotinib / Quinasa de Linfoma Anaplásico / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: J Thorac Oncol Año: 2018 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Amplificación de Genes / Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Proteínas Proto-Oncogénicas c-met / Crizotinib / Quinasa de Linfoma Anaplásico / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: J Thorac Oncol Año: 2018 Tipo del documento: Article País de afiliación: Alemania
...